← Back to Screener
GlucoTrack, Inc. Common Stock (GCTK)
Price$0.66
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-102.62%
Price vs S&P 500 (4W)-22.47%
VGM Score19.35
Market Capitalization$4.13M
All Metrics
Book Value / Share (Quarterly)$3.11
P/TBV (Annual)3.19x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-6.51
Price vs S&P 500 (YTD)-93.88%
Net Profit Margin (TTM)-3871.60%
EPS (TTM)$-20.88
10-Day Avg Trading Volume0.72M
EPS Excl Extra (TTM)$-20.88
EPS (Annual)$-1.71
ROI (Annual)-209.17%
Net Profit Margin (5Y Avg)-4767.59%
Cash / Share (Quarterly)$1.56
ROA (Last FY)-144.69%
EBITD / Share (TTM)$-16.97
ROE (5Y Avg)-117.85%
Operating Margin (TTM)-3937.33%
Cash Flow / Share (Annual)$-16.84
P/B Ratio1.46x
P/B Ratio (Quarterly)1.25x
Net Income / Employee (Annual)$-473,100
Net Interest Coverage (TTM)-333.88x
ROA (TTM)-220.10%
EPS Incl Extra (Annual)$-1.71
Current Ratio (Annual)1.61x
Quick Ratio (Quarterly)0.85x
3-Month Avg Trading Volume3.49M
52-Week Price Return-91.77%
Revenue / Employee (TTM)$-100
Tangible BV / Share (Quarterly)$0.27
P/S Ratio (Annual)19.79x
Asset Turnover (Annual)0.19x
52-Week High$15.90
Operating Margin (5Y Avg)-4535.96%
EPS Excl Extra (Annual)$-1.71
CapEx CAGR (5Y)12.62%
26-Week Price Return-86.69%
Quick Ratio (Annual)1.61x
13-Week Price Return-59.76%
Total Debt / Equity (Annual)1.21x
Current Ratio (Quarterly)0.85x
Enterprise Value$3.76M
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-1684.00%
Cash / Share (Annual)$8.11
3-Month Return Std Dev152.97%
Net Income / Employee (TTM)$-1,125,900
ROE (Last FY)-221.99%
Net Interest Coverage (Annual)-2.02x
EPS Basic Excl Extra (Annual)$-1.71
Receivables Turnover (TTM)-0.03x
Total Debt / Equity (Quarterly)1.21x
EPS Incl Extra (TTM)$-20.88
Receivables Turnover (Annual)0.00x
ROI (TTM)-289.17%
P/S Ratio (TTM)55.08x
Pretax Margin (5Y Avg)-4767.59%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.08
Price vs S&P 500 (52W)-119.98%
Year-to-Date Return-82.95%
5-Day Price Return32.00%
EPS Normalized (Annual)$-1.71
ROA (5Y Avg)-147.55%
Net Profit Margin (Annual)-1684.00%
Month-to-Date Return-22.71%
Cash Flow / Share (TTM)$-0.31
EBITD / Share (Annual)$-1.71
Operating Margin (Annual)-1678.93%
LT Debt / Equity (Annual)0.08x
ROI (5Y Avg)-107.43%
LT Debt / Equity (Quarterly)0.08x
EPS Basic Excl Extra (TTM)$-20.88
P/TBV (Quarterly)0.71x
P/B Ratio (Annual)1.25x
Pretax Margin (TTM)-3871.60%
Book Value / Share (Annual)$3.11
Price vs S&P 500 (13W)-69.50%
Beta0.63x
Revenue / Share (TTM)$-0.00
ROE (TTM)-393.33%
52-Week Low$0.43
mGradeF
vgmGradeF
Show chart for
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GCTKGlucoTrack, Inc. Common Stock | — | — | F | $0.66 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
GlucoTrack Inc is a medical device company developing long-term implantable continuous glucose monitoring (CBGM) systems. The company's GlucoTrack model provides real-time blood glucose measurement for insulin-dependent individuals and those at risk of hypoglycemia in the U.S., offering a more accurate and convenient approach to daily diabetes management.